Lecture Series on Global Health
The Department of Infectious Diseases and Tropical Medicine as member of the CIHLMU Center for International Healt proudly invite you to attend the Lecture Series on Global Health.
Pettenkoferstrasse 14, Room F1.08
At 18:00, followed by reception
Entrance is free of charge. Please note that only a limited number of seats are available and entrance will be granted on a first-come first-serve basis.
Please register online using the online application form.
Each lecture will be credited with 2 CME points by the Bavarian Regional Medical Association (BLÄK).
Wednesday, 24 October
Prof. Paul Garner, Liverpool School of Tropical Medicine
Systematic reviews: what have they ever done for tropical medicine?
Professor Paul Garner is one of the foremost leaders in the area of evidence synthesis for global health and tropical medicine.
Drawn early from his experience as medical officer in Papua New Guinea towards addressing public health issues critically, he has been instrumental in setting up systematic reviews in Tropical Medicine issues under the Cochrane Collaboration for Infectious Diseases.
A Professor at the world renowned School of Tropical Medicine in Liverpool, he leads a Cochrane network of over 300 people synthesizing research to inform global, regional and national policies in tropical infections and conditions relevant to low- and middle-income countries.
Paul Garner has also made himself known in debunking myths and misbeliefs in global health and holds honorary Professorship appointments with Chongqing Medical University (China); Christian Medical College, Vellore (India); and Stellenbosch University (South Africa): His work in Evidence Synthesis increasingly in the WHO effort in securing evidence for their guidelines.
Wednesday, 14 November
Dr. Stefan Oschmann, Merck, Director of the Executive Board & CEO
Cross-sectoral collaboration - the key to successfully combating neglected tropical diseases
Stefan Oschmann is Chairman of the Executive Board and CEO of Merck.
He joined Merck in 2011 as a member of the Executive Board and was responsible for the Healthcare business sector until the end of 2014. He drove the transformation of the Biopharma business by optimizing its cost structures and improving the efficiency of its research & development model, which included a clear portfolio prioritization.
Furthermore, he played an instrumental role in the Group-wide transformation and growth program “Fit for 2018”. Before joining Merck, Stefan Oschmann worked for the U.S. pharma company MSD, where he served in a range of senior executive positions. He started his career at an agency of the United Nations, and worked for the German Chemical Industry Association (VCI).
Stefan Oschmann was born in Würzburg, Germany in 1957. He holds a doctorate in Veterinary Medicine from Ludwig-Maximilians-Universität in Munich. He is married and has two children.
For questions or additional information, please contact email@example.com